BRAIN Biotech AG stays on solid growth path with H1 results and accelerates One-BioProducts strategy

EQS-News: BRAIN Biotech AG / Key word(s): Half Year Results/Half Year ReportBRAIN Biotech AG stays on solid growth path with H1 results and accelerates One-BioProducts strategy 25.05.2023 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.BRAIN Biotech AG stays on solid growth path...

Related Keywords

Germany ,Zwingenberg ,Hessen ,Frankfurt ,Brandenburg ,United Kingdom ,United States ,German ,Weissbiotech Gmb ,Martina Schuster ,La Schmitt Gmb ,Adriaan Moelker ,Stephanie Konle ,Biosun Biochemicals Inc ,Youtube ,Standard Of The Frankfurt Stock Exchange ,Twitter ,German Federal Ministry Of Education ,Pr Corporate Communications ,Distribution Services ,Biotech Holding ,Biocatalysts Ltd ,Biotech Group ,Linkedin ,Half Year ,Half Year Report ,Biosun Biochemicals ,Weissbiotech Gmbh ,Tailor Made Solutions ,German Federal Ministry ,Akribion Genomics ,Prime Standard ,Frankfurt Stock Exchange ,Corporate News ,Regulatory Announcements ,